Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.7K Hold
125
0.01% 399
2025
Q4
$20.5K Sell
125
-75
-38% -$11.7K 0.01% 373
2025
Q3
$26.7K Hold
200
0.01% 339
2025
Q2
$24.9K Hold
200
0.01% 305
2025
Q1
$25.4K Hold
200
0.01% 291
2024
Q4
$28.8K Hold
200
0.01% 284
2024
Q3
$29.8K Hold
200
0.01% 306
2024
Q2
$25.2K Hold
200
0.01% 311
2024
Q1
$36.8K Hold
200
0.02% 271
2023
Q4
$36K Hold
200
0.02% 272
2023
Q3
$31.8K Hold
200
0.02% 276
2023
Q2
$28.3K Sell
200
-25
-11% -$4.01K 0.02% 262
2023
Q1
$37.9K Hold
225
0.02% 236
2022
Q4
$38.1K Sell
225
-25
-10% -$4.54K 0.02% 234
2022
Q3
$47K Hold
250
0.03% 223
2022
Q2
$41K Hold
250
0.03% 224
2022
Q1
$47K Hold
250
0.03% 226
2021
Q4
$66K Hold
250
0.04% 207
2021
Q3
$72K Hold
250
0.04% 203
2021
Q2
$50K Hold
250
0.03% 229
2021
Q1
$49K Hold
250
0.03% 227
2020
Q4
$48K Hold
250
0.04% 226
2020
Q3
$37K Hold
250
0.03% 230
2020
Q2
$31K Sell
250
-50
-17% -$5.88K 0.03% 238
2020
Q1
$29K Buy
+300
New +$29K 0.03% 239

Other funds holding RGEN

CNB Bank's RGEN Position: Q1 2026 in Review

CNB Bank held its Repligen (RGEN) position steady in Q1 2026 at 125 shares worth $14.7K. The position accounts for 0.01% of the portfolio, ranked #399.

CNB Bank first reported a position in RGEN in Q1 2020 and has held it in 25 quarters since. The position peaked at $72K in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • CNB Bank held 125 shares of Repligen worth $14.7K as of Q1 2026.
  • CNB Bank left its Repligen share count unchanged in Q1 2026.
  • Repligen made up 0.01% of CNB Bank's portfolio in Q1 2026, its #399 holding.
  • CNB Bank first reported a position in Repligen in Q1 2020 and has held it in 25 quarters since.
  • CNB Bank's Repligen position peaked at $72K in Q3 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on CNB Bank's 13F filing for Q1 2026, filed 6 May 2026.